Pharma Mar | PHM - Beneficio Bruto En Ventas

Precio De Mercado
95.15
Cambio Diario
-2.05 -2.11%
Mensual
8.87%
Anual
25.94%
Q2 Expectativa
92.25




Beneficio Bruto En Ventas Cambio Fecha
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Almirall EUR 429.87M 180.02M 2025-12
Avita Medical AUD 14.31M 639K 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Ionis Pharmaceuticals USD 243M 48M 2026-03
IQVIA Holdings USD 1.12B 32M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Moderna USD 226M 583M 2025-12
Organon & Co USD 854M 3M 2025-12
Pharma Mar EUR 86.7M 53.34M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.15B 223.6M 2025-12
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12